NJBIA's Public Policy Forum: The Road to Recovery REGISTER

Scientists Demonstrate Path to Linking the Genome to Healthy Tissues and Disease
Our genomes help to determine who we are – the countless variations between individuals that encode the complexity of tissues and functions throughout the body. Since scientists first decoded a draft of the human genome more than 15 years ago, many questions have lingered, two of which have been addressed in a major new study co-led by a Princeton University computer scientist: Is it possible, despite the complexity of billions of bits of genetic information and their variations between people, to develop a mechanistic model for how healthy bodies function? Furthermore, can this model be used to understand how certain diseases emerge?

Governor Murphy Announces the Release of Final Transition Committee Reports, including Supporting our Innovation Ecosystem The gubernatorial transition team assembled by Gov. Phil Murphy and Lt. Governor Sheila Oliver today released its final reports, a reflection of the substantive debate and discussion within each committee during the transition process. The reports are committee-specific and provide a strong policy framework for the Murphy-Oliver administration. “I am proud to say that our transition was the most inclusive and diverse transition advisory process in the history of New Jersey,” Governor Murphy said.

Rowan University’s New Head of Entrepreneurship Joins at a Time of Exciting Growth
There’s a feeling of excitement in the air at the Rohrer College of Business at Rowan University. Equipped with a newfound bevy of physical and online resources, as well as a passionate new executive director of the Center for Innovation and Entrepreneurship, the University is setting its sights high as it plans its mission for 2018. “Rowan has gone through a period of explosive growth,” said Eric Liguori, who stepped into his new executive role last summer.

Liberty Science Center Celebrates 25th Anniversary Before he was the acclaimed CEO and president of Liberty Science Center, before he was a best-selling author, before he was a Class A chess player and before he was a graduate of Harvard University, Paul Hoffman was just a young boy given the opportunity to look through a telescope. “When I was 8 or 9 in Westport, Connecticut, there was a person who let me look through his telescope at the rings of Saturn,” he told an invitation-only crowd of a few hundred Thursday night.

Strategies for Retaining NJ’s Future Workforce: NJBIA White Paper New Jersey is short about 200,000 millennials. And it’s more than a simple math problem. As the largest living generation, any loss of this age group to outmigration translates to a loss of dollars to the state’s economy, both now and in the future. So said the New Jersey Business & Industry Association, which has been searching for solutions to this outmigration problem. On Thursday, the NJBIA released “The Education Equation: Strategies for Retaining and Attracting New Jersey’s Future Workforce,” a white paper prepared by a post-secondary task force created by the association.

Murphy Taps Sullivan to Head NJEDA Tim Sullivan has been selected to serve as chief executive office of the New Jersey Economic Development Authority by Gov. Phil Murphy. Sullivan currently serves as the deputy commissioner of the Connecticut Department of Economic and Community Development. He is the former chief of staff to New York City’s deputy mayor for economic development under Michael Bloomberg. The governor said it is calling on the EDA to take up the matter at its next meeting.

Life-Saving Medicines Grow from Fundamental Chemistry, Win Gates Foundation Backing By the time Robert Prud’homme visited the Bill and Melinda Gates Foundation in Seattle two years ago, his technology for encasing medicine in ultra-small particles had already led to new drug delivery approaches for high-value medical applications, including oncology. But Gates Foundation officials posed a new challenge: They wanted to use the technology to produce pediatric drugs to combat wide-spread killers in the developing world.

Rutgers Cancer Institute of New Jersey Recognized as a Center of Excellence for Work on Myelodysplastic Syndromes Rutgers Cancer Institute of New Jersey is now recognized as a Center of Excellence by the Myelodysplastic Syndromes (MDS) Foundation in the research, diagnosis and treatment of MDS disorders. Rutgers Cancer Institute hematologist/oncologist Dale Schaar, MD, PhD, who is also an associate professor of medicine at Rutgers Robert Wood Johnson Medical School, is the principal investigator of the program at Rutgers Cancer Institute. He shares more about what the new designation means for patients with an MDS diagnosis.

 

Upcoming Events

BioNJ 25th Annual Dinner Meeting & Innovation Celebration

When: Thursday, Feb. 1, 2018
Where: Hilton East Brunswick Hotel & Executive Meeting Center, 3 Tower Center Blvd., East Brunswick

7th Annual Drupal Camp NJ
When: Friday, Feb. 2, 2:30 p.m. – Sunday, Feb. 4, 3:30 p.m.
Where: Princeton University, Princeton

Tech Talks: Podcast Live with The STEM Brothers Podcast
When: Tuesday, Feb. 6, 6 p.m. – 8 p.m.
Where: Waterfront Lab – 121 Market St.- Camden

NJEN Presents: Starting, Building and Funding an Artificial Intelligence Business
When: Wednesday, Feb. 21, 5 p.m. – 8 p.m.
Where: Princeton University

WOMEN IN STEM: MED-TECH INNOVATORS
When: Tuesday, Feb.27, 4 p.m. – 6 p.m.
Where: Rutgers University Easton Auditorium (Fiber Optics Building, Busch Campus) – 101 Bevier Road – Piscataway